DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $17,089,000 | -45.3% | 3,487,620 | -32.0% | 0.00% | -42.9% |
Q2 2019 | $31,234,000 | +0.7% | 5,128,812 | -4.0% | 0.01% | -12.5% |
Q1 2019 | $31,028,000 | -61.6% | 5,340,529 | -11.0% | 0.01% | -63.6% |
Q4 2018 | $80,748,000 | -21.4% | 5,999,133 | +13.3% | 0.02% | -12.0% |
Q3 2018 | $102,798,000 | -51.1% | 5,296,133 | -35.6% | 0.02% | -44.4% |
Q2 2018 | $210,055,000 | +76.0% | 8,218,124 | +38.8% | 0.04% | +66.7% |
Q1 2018 | $119,344,000 | +581.8% | 5,922,780 | +579.1% | 0.03% | +575.0% |
Q4 2017 | $17,503,000 | -3.1% | 872,100 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $18,061,000 | +39.9% | 872,100 | 0.0% | 0.00% | +33.3% |
Q2 2017 | $12,907,000 | -7.2% | 872,100 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $13,910,000 | -19.5% | 872,100 | -36.4% | 0.00% | -25.0% |
Q4 2016 | $17,288,000 | -74.1% | 1,372,100 | -42.5% | 0.00% | -76.5% |
Q3 2016 | $66,804,000 | -2.9% | 2,385,000 | +21.3% | 0.02% | -10.5% |
Q2 2016 | $68,831,000 | +80.5% | 1,966,600 | +41.3% | 0.02% | +72.7% |
Q1 2016 | $38,130,000 | -33.6% | 1,391,600 | -17.1% | 0.01% | -31.2% |
Q4 2015 | $57,442,000 | +141.3% | 1,678,600 | +102.6% | 0.02% | +128.6% |
Q3 2015 | $23,806,000 | -43.5% | 828,600 | -12.0% | 0.01% | -36.4% |
Q2 2015 | $42,145,000 | +29.4% | 941,777 | 0.0% | 0.01% | +22.2% |
Q1 2015 | $32,567,000 | +26.3% | 941,777 | 0.0% | 0.01% | +28.6% |
Q4 2014 | $25,776,000 | – | 941,777 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|